Navigation Links
MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
Date:9/10/2009

found that LEVADEX also was effective compared to placebo in treating migraine:

  • in patients with or without allodynia;
  • at any time during the migraine attack, regardless of how long patients had waited to treat a migraine;
  • that occurs in the early morning, also known as "morning migraine";
  • in severely disabled and non disabled patients, as defined by a HIT-6 score;
  • with severe as well as moderate intensity of baseline pain;
  • with severe intensity of pain, providing pain relief at 10 minutes; and
  • with and without nausea, vomiting and aura.

Additional LEVADEX data from the Phase 3 trial showed rapid and sustained efficacy in treating migraine with:

  • pain relief at 10 minutes (p=0.16) and time to pain relief at 30 minutes (p=0.03);
  • sustained pain relief from two to 24 hours in 44 percent of patients compared to 20 percent for placebo (p<0.0001);
  • sustained pain relief from two to 48 hours in 36 percent of patients compared to 17 percent for placebo (p<0.0001, unadjusted for multiplicity); and
  • sustained pain free from two to 24 hours in 23 percent of patients compared to 7 percent for placebo, and from two to 48 hours in 18 percent of patients compared to 6 percent for placebo (p<0.0001 for both timepoints, unadjusted for multiplicity).

There were no drug-related serious adverse events reported in the trial. LEVADEX was well tolerated, with the most common adverse event reported being medication aftertaste at six percent, with two percent of patients receiving placebo also reporting medication aftertaste. The next most common adverse event was nausea at five percent, compared with two percent for placebo. Symptoms or sensitivities typically associated with commonly used triptan migraine treatments, such as ch
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... SAN DIEGO , Sept. 30, 2014   ... company developing a minimally invasive real-time 3D Cardiac Chamber ... sources that cause and / or sustain complex cardiac ... additional $26.2M financing to continue developing its imaging/mapping system ... portfolio.  The financing will allow Acutus Medical to complete ...
(Date:9/30/2014)... , Sept. 30, 2014  Life Science ... focused on supporting promising emerging biotech, medical device, ... named the Top Angel Investment Group in the ... the best performer out of 370 angel groups ... performance, network strength (connections), selection aptitude and brand ...
(Date:9/30/2014)... , Sept. 30, 2014  Synapse Biomedical Inc. ( ... enrollment of the post-approval study of its NeuRx ... needed to meet the FDA enrollment requirement was ... of schedule.  The NeuRx DPS®, which is the ... for ALS patients, is a humanitarian device that ...
Breaking Medicine Technology:Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 2Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 3
... 12 Today at the annual AdvaMed medical ... of Good Promotional Practices software, announced a partnership ... and case management solutions. Together, the companies will ... help Life Sciences companies cope with the myriad ...
... Merial, the Animal Health division of the sanofi-aventis Group (EURONEXT: ... Animal Health Co. (China) held a ground-breaking ceremony for an ... Development Zone, China. Merial Animal Health Co. (China), a ... in China has been in operation for almost 20 years. ...
Cached Medicine Technology:Prolifiq and EthicsPoint Announce Partnership: 'Automatic Alerts' Help Life Sciences Engage in Good Promotional Practices 2Prolifiq and EthicsPoint Announce Partnership: 'Automatic Alerts' Help Life Sciences Engage in Good Promotional Practices 3Merial invests US $70 million in Nanchang, China 2Merial invests US $70 million in Nanchang, China 3
(Date:9/30/2014)... A new report launched today by the Intellectual ... on Ageing) conducted by academics from the School ... has highlighted the serious, complex and unique health ... , The IDS-TILDA study is the first study ... one in the world with the ability to ...
(Date:9/30/2014)... September 30, 2014 SIMpalm, the top ... iPhone App for another great social networking music sharing ... App for iPhone®, iPad®, and iPod touch®. The App ... of music from their pre-populated ITunes account. This app ... song’s album art or photo of their choice to ...
(Date:9/30/2014)... 30, 2014 MyServer2Go.com made ... the Best VPS Hosting this year for its quality ... affordable price. , MyServer2Go.com is a professional and ... hosting services. And this announcement will help webmasters find ... to MyServer2Go.com, Arvixe ( http://www.arvixe.com ) is one of ...
(Date:9/30/2014)... The Buffet Restaurants industry ... drop in industry revenue in 2009, the industry has ... has been negatively affected by low levels of consumer ... presented itself in the form of increasing health consciousness. ... tend to use lower quality ingredients in the food ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 The ... to improve breast cancer risk prediction and to ... a study published in Breast Cancer Research (BCR ... density and breast cancer risk: a case-control study ... strong connection between breast density and breast cancer ...
Breaking Medicine News(10 mins):Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 4Health News:LYRICZ App for iPhone®, Helps You Share Images with Music to Inspire and Influence 2Health News:Arvixe Is Named Best VPS Hosting by MyServer2Go.com 2Health News:Buffet Restaurants in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Buffet Restaurants in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 2Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 4
... the Canadian Institute of Medicine it was found that fat formed ... lack a balanced diet which in turn results in various ill ... daily calories from fat which is the main cause of various ... people and questioned them about their food habits. ,Statistics ...
... from schools have met with criticism from anti-obesity lobby ... to make all schools to be soft drink-free by ... described as "misguided and based on weak evidence" by ... physicians at Starship and Auckland University. ,Professor ...
... 55 others were afflicted with the disease in Chhajli village ... an eight-year-old boy and aged woman and illness of others ... Medical teams were pressed into service today., ,Civil Surgeon ... rushed to the village to educate the people about preventive ...
... for their aches and pains could be at an ... of a new study// . ,Researchers said ... dose of acetaminophen showed abnormalities in blood tests, which ... had come across liver damage in patients who took ...
... institutes and increase the number of seats in existing facilities ... well as accommodate// the central government's proposed quota policy, says ... of seats in medical institutions and open more institutes in ... more than 4,000 doctors and this was the only to ...
... the Calcutta High Court claiming that the failure of West ... directives in keeping the metropolis clean had led to the ... has died and several others are suffering from dengue with ... ,The petitioner's lawyer Idris Ali claimed before a division ...
Cached Medicine News:Health News:Anti-Obesity Groups Criticize Response of Medical Professionals 2Health News:Even Normal Doses Of Tylenol Could Damage Liver 2
Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
... technology allows the grasper ... a shorter length and ... the stone. The Unidex ... one-handed operation. Supplied sterile ...
Bugbee Fulgurating...
Fulgurating Electrode, 2 F...
Medicine Products: